Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
What is your approach to a patient with rheumatoid arthritis and moderate disease activity on 25 mg of PO methotrexate?
Do you switch to SQ MTX, or is it best to add tx, such as a TNFi?
Answer from: at Community Practice
Switching to sub cu may work for low disease activity, but not moderate.
Sign in or Register to read more
10978
Related Questions
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
Does the presence of bronchiectasis change your approach to a patient with otherwise well-controlled patient with RA?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
How do you approach managing nausea and GI side effects when initiating methotrexate?
What is the maximum dose of leucovorin that you use with methotrexate?
Would you uptitrate methotrexate dosing when a patient flares on a TNFi and methotrexate 15 mg weekly?
How do you approach venous insufficiency management in patients on Jak inhibitors?
Can you use leflunomide and rituximab in a patient with both multiple sclerosis and rheumatoid arthritis?